Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

23.09 +0.12 (+0.52%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Why Is Nuvo Group (NUVO) Stock Up 200% Today?
Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger. 
Via InvestorPlace
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?
Baxter reports Q1 adjusted EPS at $0.65, up 10% Y/Y, surpassing expectations. Sales hit $3.59 billion, with 2% growth on a reported basis. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q1 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Dividend Stocks For 10%+ Annual Returns
Buying undervalued dividend stocks with growth potential could lead to above-average returns. 
Via Talk Markets
Assessing Baxter Intl: Insights From 4 Financial Analysts
 
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Baxter International Inc. (NYSE: BAX) Highlighted for Surprising Price Action
Via Investor Brand Network
Baxter Reports First-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducing cognitive burden. Explore enhanced safety features & EMR interoperability. 
Via Benzinga
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
From Baxter International Inc.
Via Business Wire
Baxter to Host Annual Meeting of Stockholders in Virtual Format
From Baxter International Inc.
Via Business Wire
Becton, Dickinson And Co. Dividend Stock Analysis
Becton, Dickinson, and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs, and other settings. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
Via Benzinga
Baxter to Present at Raymond James 45th Annual Institutional Investors Conference
From Baxter International Inc.
Via Business Wire
Stock Market Commentary: “Volumes Are The Name Of The Game…”
Short, intermediate, and long term outlook on the market. Plus, a deep dive into our thesis on Cooper Standard 
Via Talk Markets
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Barclays Maintains Overweight Rating for Baxter Intl: Here's What You Need To Know
 
Via Benzinga
Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit
Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, Therapies, Kidney Care, and Pharmaceuticals segments. 
Via Benzinga
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
From Baxter International Inc.
Via Business Wire
Top Picks 2024: Baxter International
Baxter International (BAX) has four divisions: Medical Products & Therapies, Healthcare Systems & Technologies, Pharmaceuticals, and Kidney Care. The stock aggressively sold off ~65% 
Via Talk Markets
Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. 
Via Talk Markets
3 Of Our Favorite Dividend Stocks For The New Year
The S&P 500 Index appears to be wrapping up a strong year, registering a year-to-date total return of 22.2%. The good news is that there are still undervalued stocks with strong dividends to choose... 
Via Talk Markets
Topics Stocks
Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals
From Baxter International Inc.
Via Business Wire
Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Baxter International Inc.
Via Business Wire
Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.